Source - SMW
Berenberg today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1760p (from 1835p).

Related Charts

GlaxoSmithKline (GSK)

-11.75p (-0.89%)
delayed 11:59AM